Anti-Aging & Longevity — Peptide Research Overview

Relevant Compounds

• Epitalon — A tetrapeptide from the pineal gland studied for telomerase activation and regulation of melatonin and cortisol.
• NAD+ — Nicotinamide adenine dinucleotide; critical coenzyme for mitochondrial energy production and sirtuin activation. Declines sharply with age.
• GHK-Cu — Copper tripeptide studied for gene expression modulation, wound healing, and reversal of senescence-related gene changes.
• MOTS-c — Mitochondrial-derived peptide that activates AMPK and promotes metabolic homeostasis. Associated with longevity in human genetic studies.

What the Research Shows

Epitalon

[Animal Study / Preliminary Human] Russian research from the 1980s–2000s demonstrated Epitalon's ability to activate telomerase in somatic cells and extend mean lifespan in rodents. Small human studies (Khavinson et al.) showed normalization of melatonin secretion and improved immunological parameters in elderly subjects. Evidence quality is limited by study size and replication constraints. The tetrapeptide (Ala-Glu-Asp-Gly) is a synthetic version of epithalamin, a pineal gland extract first isolated by Professor Vladimir Khavinson.

In animal models, Epitalon extended mean lifespan by 12-15% and maximum lifespan by approximately 13% in mice and rats. The mechanism appears to involve telomerase activation in somatic cells, which are normally telomerase-negative after differentiation. Telomere length maintenance is associated with cellular rejuvenation and reduced senescence signaling. Additionally, Epitalon appears to normalize circadian rhythm disruptions common in aging, restoring melatonin secretion patterns and cortisol rhythms.

Human studies have been limited to small cohorts, mostly published in Russian journals with limited Western peer review. Reported benefits include improved sleep quality, normalized hormone levels, enhanced immune function (particularly T-cell markers), and reduced oxidative stress biomarkers. The typical protocol involves subcutaneous or intramuscular injection of 10 mg daily for 10-20 days, repeated 2-4 times per year. Safety data from these trials suggest minimal adverse effects, though long-term safety and efficacy remain incompletely characterized.

NAD+

[Human Trial] Multiple human trials on NAD+ precursors (NMN, NR) demonstrate that IV or oral administration restores NAD+ levels in muscle and blood. Improved insulin sensitivity, reduced DNA damage markers, and enhanced mitochondrial biogenesis have been observed. IV NAD+ is the most direct delivery method with the most consistent results in clinical settings. NAD+ levels decline by approximately 50% between ages 40 and 60, contributing to mitochondrial dysfunction, impaired DNA repair, and reduced sirtuin activity.

Sirtuins are NAD+-dependent deacetylases that regulate gene expression related to stress resistance, inflammation, and metabolic homeostasis. SIRT1, SIRT3, and SIRT6 have been particularly implicated in longevity pathways. NAD+ is also essential for PARP enzymes involved in DNA repair, which become hyperactive in response to age-related DNA damage, further depleting NAD+ stores in a vicious cycle. Restoring NAD+ breaks this cycle and enhances cellular repair capacity.

Clinical trials using NMN (250-500 mg oral daily) and NR (500-1000 mg oral daily) have shown increases in circulating NAD+ metabolites, improved insulin sensitivity in prediabetic individuals, enhanced muscle mitochondrial function, and reduced arterial stiffness. IV NAD+ infusions (ranging from 250-1000 mg per session) produce more dramatic acute increases in NAD+ levels and have been associated with subjective improvements in energy, mental clarity, and physical performance, though placebo-controlled data is limited. The optimal dosing, frequency, and long-term effects remain under investigation.

GHK-Cu

[Human Trial / Animal Study] GHK-Cu has been tested in human wound healing trials with positive results. In vitro data shows it resets the gene expression of aging fibroblasts toward a younger phenotype, modulates ~4,000 genes, and reduces oxidative stress markers. Topical and systemic administration have been studied. The tripeptide naturally occurs in human plasma at levels around 200 ng/mL in youth, declining to 80 ng/mL by age 60.

The copper complex form enhances stability and biological activity. Gene expression studies reveal that GHK-Cu upregulates genes involved in collagen synthesis, angiogenesis, antioxidant defenses, and nervous system function while downregulating genes associated with inflammation, fibrosis, and cancer progression. This gene-regulatory effect appears to partially reverse age-related epigenetic changes, particularly in fibroblasts and keratinocytes.

In wound healing trials, topical GHK-Cu accelerated closure rates, improved scar appearance, and enhanced tissue remodeling compared to controls. Systemic administration (subcutaneous injection of 1-3 mg daily) has been explored in small studies for skin health, hair growth, and systemic anti-inflammatory effects. Anecdotal reports suggest improvements in skin texture, elasticity, and appearance, as well as enhanced recovery from injuries. Safety appears favorable with minimal reported adverse effects, though large-scale long-term trials are lacking.

MOTS-c

[Animal Study / Preliminary Human] MOTS-c is encoded in mitochondrial DNA and activates AMPK, promoting metabolic flexibility and resilience to oxidative stress. In mice, it extends lifespan and improves insulin sensitivity. Human genetic variants associated with longevity have been linked to MOTS-c expression. Clinical human trials are early-stage. MOTS-c is one of several mitochondrial-derived peptides (MDPs) that act as signaling molecules linking mitochondrial function to systemic metabolism.

AMPK activation by MOTS-c mimics some effects of caloric restriction and exercise, two of the most robust longevity interventions. This includes enhanced glucose uptake independent of insulin, increased fatty acid oxidation, mitochondrial biogenesis, and activation of autophagy. In animal models, MOTS-c administration prevented age-related and diet-induced insulin resistance, preserved physical performance in aged mice, and extended lifespan when initiated late in life.

Human studies have identified a common polymorphism (K14Q) in the MOTS-c sequence that is associated with exceptional longevity in Japanese and Korean populations. This variant appears to enhance MOTS-c stability and activity. Preliminary human trials examining exogenous MOTS-c administration are underway, evaluating effects on metabolic parameters, exercise capacity, and biomarkers of aging. Dosing protocols in early studies range from 5-15 mg subcutaneously 2-3 times weekly.

How These Compounds Work

These longevity compounds target distinct but interconnected aging mechanisms. Epitalon addresses telomere attrition and circadian rhythm dysfunction, two hallmarks of aging that affect cellular replicative capacity and hormonal regulation. Telomerase activation in somatic cells is controversial given theoretical cancer risk, but short-term pulsed use may provide benefits without sustained activation that could promote tumor growth.

NAD+ restoration addresses the fundamental energy crisis of aging cells. As NAD+ levels decline, mitochondrial ATP production becomes impaired, DNA repair slows, and sirtuins lose activity. This creates a cascade of dysfunction affecting nearly every cellular process. NAD+ precursors or direct NAD+ supplementation reverses this deficit, enhancing cellular energetics and stress resistance.

GHK-Cu works through gene expression modulation, acting as an epigenetic regulator that shifts cells away from pro-inflammatory, senescent patterns toward regenerative, youthful states. The copper component is essential for its activity, participating in redox reactions and serving as a cofactor for enzymes involved in collagen crosslinking and antioxidant defense.

MOTS-c operates as a mitochondria-to-nucleus retrograde signaling molecule, informing the cell about mitochondrial status and activating adaptive stress responses. By activating AMPK, it shifts metabolism toward catabolic, repair-focused pathways similar to those activated by fasting or exercise.

Who Is This For?

These compounds are primarily relevant for individuals focused on optimizing healthspan and potentially extending lifespan through evidence-based interventions. Ideal candidates are typically 40+ years old, when age-related declines in NAD+, hormonal function, and cellular repair become measurable. Younger individuals may not experience significant benefits given their already-robust endogenous levels of these factors.

Those with biomarkers indicating accelerated aging—such as elevated inflammatory markers, poor metabolic health, declining physical or cognitive performance, or evidence of mitochondrial dysfunction—may derive particular benefit. Individuals with a family history of age-related diseases or those seeking to maintain function and vitality as they age are also appropriate candidates.

These interventions are not appropriate substitutes for foundational health practices. Diet, exercise, sleep, stress management, and social connection remain the most validated longevity interventions. Peptide and supplement-based approaches should be considered adjuncts, not replacements, for lifestyle optimization. Additionally, because none of these compounds are FDA-approved for anti-aging, use is off-label and should be approached with informed consent and medical supervision.

Protocol Considerations

Epitalon is typically administered as a short course (10-20 days) of daily subcutaneous injections (5-10 mg), repeated 2-4 times per year. This pulsed approach may minimize theoretical risks associated with sustained telomerase activation while providing periodic benefits. Some protocols combine it with other longevity peptides or administer it around significant stress periods or seasonal changes.

NAD+ supplementation can be approached through oral precursors (NMN 250-500 mg daily, NR 500-1000 mg daily) or IV infusions (250-1000 mg weekly or monthly). Oral precursors are more convenient and cost-effective but have variable absorption and conversion efficiency. IV administration produces more predictable increases in NAD+ levels but requires clinical access and is more expensive. Sublingual NAD+ formulations are also available as a middle ground.

GHK-Cu can be used topically for skin benefits (creams containing 0.05-2% GHK-Cu) or systemically via subcutaneous injection (1-3 mg daily or several times weekly). Systemic use is more experimental. Combining GHK-Cu with vitamin C may enhance collagen synthesis, while copper status should be monitored to avoid excess accumulation.

MOTS-c protocols in early human studies use 5-15 mg subcutaneously 2-3 times weekly. Optimal dosing and frequency are still being determined. Given its metabolic effects, combining MOTS-c with exercise may enhance benefits, as exercise is itself a stimulus for mitochondrial adaptation.

What to Track

Biological Age Markers: DNA methylation clocks (Horvath, GrimAge, PhenoAge), telomere length, inflammatory markers (hs-CRP, IL-6), advanced glycation end products (AGEs).

Metabolic Health: Fasting glucose, fasting insulin, HbA1c, HOMA-IR (insulin resistance index), lipid panel, liver enzymes, kidney function.

Physical Function: VO2 max or cardiorespiratory fitness testing, grip strength, walking speed, balance tests (one-leg stand time), muscle mass (DEXA or bioimpedance).

Cognitive Function: Subjective cognitive assessments, formal neuropsychological testing if indicated, Montreal Cognitive Assessment (MoCA) or similar screening tools.

Subjective Markers: Energy levels, sleep quality (sleep tracking devices), perceived stress, overall quality of life. These often change before objective biomarkers and can guide protocol adjustments.

Safety Monitoring: Complete blood count, comprehensive metabolic panel, and for copper-containing compounds, serum copper and ceruloplasmin levels. Thyroid function and sex hormones may be relevant depending on baseline status and concerns.

Evidence Summary